March 13, 2002JAMA2,223 citations
View Full PaperHypertrophic Cardiomyopathy
Structured PICO
P
Population
Patients with Hypertrophic Cardiomyopathy (HCM)
Provides a contemporary overview of hypertrophic cardiomyopathy, emphasizing that the condition is often compatible with normal longevity.
Abstract
Substantial understanding has evolved regarding the epidemiology and clinical course of HCM, as well as novel treatment strategies that may alter its natural history. An appreciation that HCM, although an important cause of death and disability at all ages, does not invariably convey ominous prognosis and is compatible with normal longevity should dictate a large measure of reassurance for many patients.